Renal Cancer - Results from #5880

Efficacy and Toxicity of Mammalian Target Rapamycin Inhibitors in Patients with Metastatic Renal Cell Carcinoma with Renal Insufficiency: The Korean Cancer Study Group GU 14-08 February 15, 2016

Management of toxicities of immune checkpoint inhibitors February 15, 2016

Contemporary Status of Percutaneous Ablation for the Small Renal Mass February 15, 2016

Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy February 15, 2016

High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma February 11, 2016

Perineural spread of renal cell carcinoma: a case illustration with a proposed anatomic mechanism and a review of the literature February 11, 2016

Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers February 11, 2016

Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up February 11, 2016

Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene February 10, 2016

Identifying molecular genetic features and oncogenic pathways of clear cell renal cell carcinoma through the anatomical (PADUA) scoring system February 10, 2016

Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma February 9, 2016

Are primary renal cell carcinoma and metastases of renal cell carcinoma the same cancer? February 8, 2016

Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study February 8, 2016

A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review February 8, 2016

Pazopanib in the treatment of advanced renal cell carcinoma February 8, 2016

A Randomized Phase 2/3 Study of Naptumomab Estafenatox + IFN-α vs IFN-α in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis. February 7, 2016

Sunitinib activates Axl signaling in renal cell cancer February 5, 2016

SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer February 5, 2016

Baseline tumor volume in assessing prognosis of patients with intermediate-risk synchronous metastatic renal cell carcinoma February 3, 2016

Combined Angiogenesis and Proliferation Markers' Expressions as Long-Term Prognostic Factors in Renal Cell Cancer February 3, 2016

Page 295 of 458